Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
2.310
+0.050 (2.21%)
At close: Aug 5, 2025, 4:00 PM
2.280
-0.030 (-1.28%)
After-hours: Aug 5, 2025, 7:54 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $358.32 million as of August 5, 2025. Its market cap has decreased by -60.15% in one year.
Market Cap
358.32M
Enterprise Value
377.99M
1-Year Change
-60.15%
Ranking
Category
Stock Price
$2.31
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $358.32M, an increase of 188.26%. That is a compound annual growth rate of 25.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 358.32M | -44.85% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
| Dec 1, 2020 | 124.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.36B |
| Johnson & Johnson | 411.95B |
| AbbVie | 348.32B |
| AstraZeneca | 229.32B |
| Abbott Laboratories | 226.10B |
| Novartis AG | 224.47B |
| UnitedHealth Group | 218.60B |
| Novo Nordisk | 215.34B |